Skip to main content

Published locations for Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLL

User login

  • Reset your password
  • /content/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results-first-line-cll
  • /hematologynews/article/167701/cll/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results-first
  • /jcso/article/167701/cll/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results-first-line-cll
  • /oncologypractice/article/167701/cll/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results-first
  • /hematologynews/nhlhub/article/167701/cll/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results
  • /hematology-oncology/article/167701/cll/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results
  • /b-cell-lymphoma-icymi/article/167701/cll/venetoclax-plus-ibrutinib-yields-encouraging-mrd-results